THEMIS MEDICARE share price has zoomed 14% and is presently trading at Rs 279.8.
Meanwhile, the BSE HEALTHCARE index is at 44,226.1 (up 1.0%).
Among the top gainers in the BSE HEALTHCARE index today are FDC (up 10.3%) and MAX HEALTHCARE INSTITUTE (up 4.6%).
GRANULES INDIA (down 10.0%) and POLY MEDICURE (down 0.8%) are among the top losers today.
Over the last one year, THEMIS MEDICARE has moved up from Rs 162.2 to Rs 279.8, registering a gain of Rs 117.6 (up 72.5%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,436.8 to 44,226.1, registering a gain of 55.5% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 132.2%), SUVEN PHARMACEUTICALS (up 128.7%) and Glenmark Pharma (up 114.2%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 81,734.7 (up 0.3%).
The top gainers among the BSE Sensex today are Kotak Bank (up 1.4%) and NTPC (up 1.4%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 25,002.2 (up 0.3%). Shriram Transport and Hero Motocorp are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 67,127.1 to 81,734.7, registering a gain of 14,607.6 points (up 21.8%).
THEMIS MEDICARE net profit grew 49.0% YoY to Rs 187 million for the quarter ended June 2024, compared to a profit of Rs 126 million a year ago. Net sales rose 27.3% to Rs 1,230 million during the period as against Rs 966 million in April-June 2023.
For the year ended March 2024, THEMIS MEDICARE reported 23.5% decrease in net profit to Rs 435 million compared to net profit of Rs 569 million during FY23. Revenue of the company grew 7.7% to Rs 3,818 million during FY24.
The current Price to earnings ratio of THEMIS MEDICARE, based on rolling 12 month earnings, stands at 83.4.
Equitymaster requests your view! Post a comment on "THEMIS MEDICARE Gains 14%; BSE HEALTHCARE Index Up 1.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!